Changing HER2-status of the primary gastric tumor after neoadjuvant trastuzumab-based therapy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback